Adverse events in autologous blood donation and plasmapheresis - A 6- year analysis in 28,244 patients with 50,542 donations

Infusionstherapie und Transfusionsmedizin

Volumn 26, Issue 5, 1999, Pages 272-277

  Singbartl, G ^c   Schleinzer, W ^a,b  

^a Neue Pergamon K   (Germany)

^b SWISS PARAPLEGIC RESEARCH   (Switzerland)

^c ENDO Klinik   (Germany)

Author keywords

Adverse events; Autologous blood donation; Autologous plasma donation; Autologous plasmapheresis; Autologous predeposit

Indexed keywords

ADULT; AGED; ANAPHYLAXIS; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; COLLAPSE; DIAPHORESIS; HEALTH STATUS; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; PALLOR; PATIENT SELECTION; PLASMAPHERESIS; PREOPERATIVE PERIOD; SYNCOPE; THORAX PAIN; VERTIGO;

EID: 0032822640     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053504     Document Type: Article

References (16)

1. Vrielink H, Reesink HW: Virus transmission by allogenous blood and blood components Baillieres Clin Anaesthesiol 1997;11:185-204.
2. Karger R, Weippert-Kretschmer M, Kretschmer V: Preoperative autologous blood and plasma donation and retransfusion. Baillieres Clin Anaesthesiol 1997;11:319-333.
3. Domen RE, Ribicki LA, Hoeltge GA: An analysis of autologous blood donor motivational factors. Vox Sang 1995;69:110-113.
4. Goodnough LT, Bravo JR, Hsueh YS, Keating LJ, Brittenham GM: Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment for autologous blood crossover and directed blood transfusion. Transfusion 1989;29:821-822
5. Kasper SM, Gerlich W, Buzello W: Preoperative red cell production in patients undergoing weekly autologous blood donation. Transfusion 1997;37: 1058-1062.
6. Singbartl G, Bauermann E, Röhrs E: Erythrozytengewinn durch praeoperative Eigen-Blutspende - rote Zellen oder rote Zahlen? Infusionsther Transfusionsmed 1998;25(suppl 1):56(abstract).
7. Isbister JP: Autotransfusion: An impossible dream? Anaesth Intensive Care 1984;12:236-240.
8. McVay PA, Andrews A, Hoag MS, Polan D, Skettino S, Stehling LC, Strauss RG, Toy PTCY: Moderate and severe reactions during autologous donations are no more frequent than during homologous blood donations. Vox Sang 1990;59:70-72.
9. AuBuchon JP, Popovsky MA: The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion 1991;31:513-517.
10. Popovsky MA, Whitacker B, Arnold N: Severe outcomes of allogeneic and autologous blood donation: Frequency and characterization. Transfusion 1994;35:734-737.
11. Pindyck J, Avorn J, Kuriyan M, Reed M, Iqbal MJ, Levine SJ: Blood donation by the elderly. Clinical and policy considerations. JAMA 1987;257:1186-1188.
12. Goldfinger D, Capon S, Czer L, Leibfried J, Trento A, Ross D, Waters P, Klapper E, Pepkowitz S: Safety and efficacy of preoperative donation of blood for autologous use by patients with end-stage heart or lung disease who are awaiting organ transplantation. Transfusion 1993;33:336-340.
13. Spiess BD, Sassetti R, McCarthy RJ, Narbone RF, Tuman KJ, Ivankovich AD: Autologous blood donation: Hemodynamics in a high-risk patient population. Transfusion 1992;32:17-22.
14. Dahlmann H, Kasper M, Gerlich W, Rieke M: Volumenersatz bei der Eigenblutspende von Patienten mit kardiovaskulären Risikofaktoren. Anaesthesist 1991;14(suppl 1):S107(abstract).
15. Kröll W, Gerner P, Pölz W: Vergleichende Untersuchung zur Volumenwirkung körperfremder Kolloide. Perfusion 1993;6:286-299.
16. Glück D, Maurer C, Kubanek B, und die Studiengruppe Berufsverband Deutscher Transfusions-mediziner e.V.: Infektionsmarker bei Blutspenden. Aus der Studie zur Epidemiologie von HIV-und Hepatitisinfektionen bei Blutspendern. Infusionsther Transfusionsmed 1997;24:167-170.